Nothing in this Policy limits or excludes any rights you may have under the laws of your country of residence
To view a copy of this licence, visit About this article Cite this article Buonanno, S., Gaggiano, C., Terribili, R
[11] [12] Currently available GLP-1 receptor agonists in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist
It is also prohibited in sport by WADA
This guide covers every injection site in plain language: where to inject, how to inject correctly, why rotation matters, what mistakes to avoid, and what the clinical data says about absorption differences between the stomach, thigh, and arm